|
|
||||||||
Radiation Oncology |
1 Departments of Radiation Oncology (Y.K.O., C.S.H., J.D.C.)
2 Diagnostic Radiology (B.I.S.)
3 Hematology (F.C., M.A.H.), University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.
PURPOSE: To evaluate the efficiency of axial computed tomography (CT) in detecting relapses of stage I, II, or III follicular lymphoma.
MATERIALS AND METHODS: A total of 328 patients with previously untreated stage I, II, or III follicular lymphoma were treated between 1978 and 1994. Two hundred fifty-seven patients achieved complete response; 78 who relapsed form the basis of this study. Fifteen patients had stage I; 28, stage II; and 35, stage III disease. Fifteen patients underwent radiation therapy; 12, chemotherapy; and 51, radiation and chemotherapy. Medical records were reviewed to analyze the yield of abdominal and pelvic CT in detecting recurrence relative to the yield of standard clinical, hematologic, and imaging studies. A positive study was defined as one that led to or was abnormal at the diagnosis of recurrence.
RESULTS: The median follow-up was 101 months. Eleven relapses were detected only at abdominal, pelvic, or both abdominal and pelvic CT.
CONCLUSION: Fourteen percent (11 of 78) of the relapses were detected solely at abdominal and/or pelvic CT. Eleven (4.3%) of the 257 patients who achieved complete response benefited from abdominal and pelvic CT. The yield of the routine use of abdominal and pelvic CT in follow-up studies appears to be low for stages IIII follicular lymphoma.
Index terms: Lymphography, 99.125 Lymphoma, 99.30, 99.8, 99.83 Lymphoma, CT, 99.1291 Lymphoma, diagnosis, 70.11, 80.11, 99.125, 99.1261, 99.1262, 99.1291
This article has been cited by other articles:
![]() |
B. Cheson The Case Against Heavy PETing J. Clin. Oncol., April 10, 2009; 27(11): 1742 - 1743. [Full Text] [PDF] |
||||
![]() |
P. Seam, M. E. Juweid, and B. D. Cheson The role of FDG-PET scans in patients with lymphoma Blood, November 15, 2007; 110(10): 3507 - 3516. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Cheson, B. Pfistner, M. E. Juweid, R. D. Gascoyne, L. Specht, S. J. Horning, B. Coiffier, R. I. Fisher, A. Hagenbeek, E. Zucca, et al. Revised Response Criteria for Malignant Lymphoma J. Clin. Oncol., February 10, 2007; 25(5): 579 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Schwartz, M K Gospodarowicz, K Khalili, M Pintilie, S Goddard, A Keller, and R W Tsang An audit of imaging test utilization for the management of lymphoma in an oncology hospital: implications for resource planning? Br. J. Radiol., February 1, 2006; 79(938): 116 - 122. [Abstract] [Full Text] [PDF] |
||||